In a BSE filing, Granules said the US Food and Drug Administration
(USFDA) has approved the abbreviated new drug application (ANDA) filed
by Granules Pharmaceuticals, Inc (GPI), a wholly-owned foreign
subsidiary of Granules India Ltd, for Potassium Chloride Oral Solution
USP.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-arm-gets-american-health-regulators-nod-for-potassium-chloride-oral-solution/articleshow/80624250.cms
No comments:
Post a Comment